期刊文献+

脾加骨髓细胞移植治疗小鼠大肠癌的实验研究

Experiment Research on the Spleen and Bone Marrow Cell Transplantation in the treatment of Colorectal Cancer in Mice
原文传递
导出
摘要 目的:探讨半相合脾加骨髓细胞移植治疗小鼠大肠癌的效果及其对嵌合体水平和移植物抗宿主病(GVHD)的影响。方法:以接种CT26大肠癌细胞的BALB/c×C57BL/6杂交Fl代雌性小鼠为受鼠,以健康雌性Fl、雄性C57BL/6、雄性C3H小鼠为MHC全相合、半相合、不相合供鼠,观察移植后的抑瘤情况;另设5只化疗联合半相合脾加骨髓细胞移植的小鼠为监测组,用来作嵌合体的分析,观察各组GVHD的情况。结果:经化疗预处理的脾加骨髓细胞移植组小鼠肿瘤明显缩小,与单纯化疗未进行移植组比较,差异具有统计学意义(P<0.05);化疗联合半相合脾加骨髓细胞移植的小鼠于移植3周后达完全供者植入,于移植后第10天左右出现纳差、倦怠、步态不稳、脱毛、腹泻、体重明显下降等GVHD的症状。结论:化疗预处理联合脾加骨髓细胞移植能对CT26大肠癌细胞产生GVT效应,并伴随着GVHD及嵌合率的变化。 Objective: To investigate the anti-tumor effects and the effect condition of the chimera level and GVHD of transplanting MHC half-matched bone marrow cells combined with spleen cells in a murine model bearing colorectal cancer. Methods: Female (BALB/exC57BI/6)FI mice (CB6FI, H-2Kb/d) were subcutaneously inoculated with CT26 cells to develop a solid tumor model. The syngenic, half-matched, and mismached donor bone marrow cells were from healthy female FI, maleC57BL/6 (H-2Kb), and male C3H (H-2K)mice, respectively. The tumor weights were measured after transplantation. Meanwhile, the testing-group which received chemotherapy, transplanting MHC half-matched bone marrow cells combined with spleen cells was used to analyze the chimera level. And GVHD were observed after the transplantation. Results: The tumor weights of mice undergone chemotherapy pretreatment, bone marrow cells combined with spleen cells were significantly decreased compared with those of the mice receiving chemotherapy alone (P 〈0.05). The mice which received chemotherapy, transplanting MHC half-matched bone marrow cells combined with spleen cells attained donor implanted completely in 3 weeks after transplantation. Then began to fall ill at 10 days post-transplantation, GVHD symptoms including decreased appetite, tired,instability of gait, unhairing, lose weight, diarrhea. Conclusion: Transplantation of chemotherapy preprocess, MHC bone marrow cells combined with spleen cells could induce GVT effect in mice bearing CT26 tumor, which accompanied with the change of GVHD and ehimerism.
出处 《现代生物医学进展》 CAS 2014年第16期3005-3009,共5页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(30972878)
关键词 骨髓细胞移植 化疗 大肠癌 移植物抗宿主病 移植物抗肿瘤效应 Bone marrow transplantation Chemotherapy Colorectal cancer Graft-versus-host disease(GVHD) Graft-versus- tumor effect(GVT)
  • 相关文献

参考文献20

  • 1Jemal A, Siegel R, Ward E, et al. Cancer stastics 2008[J]. CA Cancer J Clin,2008,58(2):71-96.
  • 2Carnevale-Schianca F, Cignetti A, Capaldi A, et al. Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD [J]. Blood, 2006, 107(9): 3795-3803.
  • 3Bay JO, Fleury J, Choufi B, et al. Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma:results of five patients [J]. BoneMarrow Transplant, 2002, 30(2): 95-102.
  • 4Sureda A, Schmitz N. Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies [J]. Ann- Hematol, 2003, 82(1): 1-13.
  • 5Sprangers B, Van Wijmeersch B, Fevery S, et al. Experimental and clinical approaches for optimization of the graft-versus-leukemia effect[J]. Nat Clin Pract Oncol, 2007,4(7):404-414.
  • 6Liang PK and Chao NJ. Non-myeloablative Allogeneie Hematopoietic Stem Cell Transplant Using Mismatched / Haploidentical Donors: A review[J]. Blood Cells Mol Dis, 2008,40(1): 20-24.
  • 7Deol A, Luml G. Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited [J]. Cancer Treat Rev, 2010, 36(7): 528-538.
  • 8Kamimura T, Miyamoto T, Kawano N, et al. Successful treatment by donor lymphocyte infusion of adult T-cell leukemia / lymphoma relapse following allogeneic hematopoietic stem cell transplantation [J]. Int J Hematol, 2012,95( 6):725-730.
  • 9潘耀柱,欧英贤,白海,王存邦,魏亚明,达万明,王小靖.混合嵌合体与GVHD、GVT的临床研究[J].中国现代医学杂志,2003,13(10):119-121. 被引量:1
  • 10Costa LJ, Kumar S, Dispenzieri A, et al. Factors associated with favor-able outcome after allogeneic hematopoietic stem cell transplan- tation for multiple myeloma [J]. Leuk Lymphoma, 2009,50 (5): 781-787.

二级参考文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部